Table 1. Cutaneous phenotype of the CMN cohort.
Projected adult size of largest CMN (cm) | N (%) | Site of largest CMN | N (%) |
---|---|---|---|
<10 | 35 (21) | Face | 10 (6) |
10–20 | 28 (17) | Scalp | 19 (12) |
20–40 | 27 (16) | Neck | 85 (51) |
40–60 | 24 (15) | Trunk | 25 (15) |
>60 | 48 (29) | Scalp/neck/trunk | 9 (6) |
No single larger lesion | 4 (2) | Face/scalp | 14 (8) |
Missing data | 0 | No single larger lesion | 4 (2) |
Missing data | |||
Total | 166 (100) | Total | 166 (100) |
Total number of other nevi at birth |
N (%) |
Total number of other nevi at enrollment |
N (%) |
0 | 28 (17) | 0 | 28 (17) |
1–10 | 37 (22) | 1–10 | 25 (15) |
11–20 | 25 (15) | 11–20 | 20 (12) |
21–50 | 26 (16) | 21–50 | 19 (11) |
51–100 | 17 (10) | 51–100 | 22 (13) |
101–200 | 8 (5) | 101–200 | 28 (17) |
>200 | 3 (2) | >200 | 18 (11) |
Missing data | 22 (13) | Missing data | 6 (4) |
Total | 166 (100) | Total | 166 (100) |
Abbreviation: CMN, congenital melanocytic nevi.